<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Journal of the Islamic Republic Of Iran</title>
<title_fa>مجله پزشکی جمهوری اسلامی ایران</title_fa>
<short_title>Med J Islam Repub Iran</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mjiri.iums.ac.ir</web_url>
<journal_hbi_system_id>2</journal_hbi_system_id>
<journal_hbi_system_user>journal2</journal_hbi_system_user>
<journal_id_issn>1016-1430</journal_id_issn>
<journal_id_issn_online>2251-6840</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.18869/mjiri</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1384</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2005</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<volume>19</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>ADENOSINE DEAMINASE ACTIVITY IN ESTROGEN RECEPTOR POSITIVE AND NEGATIVE HUMAN BREAST CANCER CELL LINES</title>
	<subject_fa> Clinical Biochemistry</subject_fa>
	<subject> Clinical Biochemistry</subject>
	<content_type_fa>Original Research: Basic Science in Medicine</content_type_fa>
	<content_type>Original Research: Basic Science in Medicine</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt; &lt;strong&gt;ABSTRACT&lt;/strong&gt;&lt;/p&gt;&lt;p&gt; &lt;strong&gt;Background:&lt;/strong&gt; The aims of this study were to assay the activity of adenosine deaminase (ADA) in estrogen receptor positive (MCF-7) and negative (MDA-MB468) breast cancer cell lines.&lt;/p&gt;&lt;p&gt; &lt;strong&gt;Methods:&lt;/strong&gt; MDA-MB468 and MCF-7 breast cancer cell lines were cultured in complete medium, striped serum with and without 0.0 1~-LM diethylstilbestrol (DES), complete medium in the presence and absence of 111M tamoxifen for 20 hr. Adenosine deaminase activity was determined using the colorimetric method described by Guisti and Galanti.&lt;/p&gt;&lt;p&gt; &lt;strong&gt;Results:&lt;/strong&gt; It was found that the activity of enzyme in estrogen receptor positive (ER+) cell line (MCF-7) was significantly higher than that of estrogen receptor negative breast cancer cell line (MDA-MB468). ADA activity in MCF-7 cells cultured in the presence of tamoxifen or charcoal-striped serum was significantly lower than that of control. Furthermore addition of diethylstilbestrol (DES) to the striped serum increased the value of ADA activity to that of control. Unlike MCF-7 cells, the activity of ADA in MDA-MB468 cells remained unchanged upon treatment with tamoxifen or striped serum.&lt;/p&gt;&lt;p&gt; &lt;strong&gt;Conclusion:&lt;/strong&gt; These findings suggest estrogen responsiveness of ADA expression in MCF-7 cells.&lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Adenosine deaminase, breast cancer cell lines, estrogen receptor.</keyword>
	<start_page>53</start_page>
	<end_page>56</end_page>
	<web_url>http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1-261&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>MOHAMMAD </first_name>
	<middle_name></middle_name>
	<last_name>HASHEMI</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mhdhash@yahoo.com</email>
	<code>20031947532846006682</code>
	<orcid>20031947532846006682</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Dept. of Clinical Biochemistry, Zahedan Medical University, Zahedan , Iran .</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>FATEMEH  </first_name>
	<middle_name></middle_name>
	<last_name>KARAMI TEHRANI</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846006683</code>
	<orcid>20031947532846006683</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Cancer Research Lab, Dept. of Clinical Biochemistry, School of Medical Sciences, Tarbiat ModarresUniversity, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>SAEID</first_name>
	<middle_name></middle_name>
	<last_name>GHAVAMI</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846006684</code>
	<orcid>20031947532846006684</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Dept. of Clinical Biochemistry, School of Medicine, Zahedan Medical University, Zahedan, Iran,</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>MAJID</first_name>
	<middle_name></middle_name>
	<last_name> SIRATI SABET</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846006685</code>
	<orcid>20031947532846006685</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Dept. of Clinical Biochemistry, School of Medicine, Qazvin MedicalUniversity, Qazvin, Iran. </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
